ASCO® 2025 Highlights: Presenter Vignette – Michael Atkins
Michael Atkins
MD, FAIO, FASCO
Georgetown University Medical Center
9506
DREAMseq: A phase III trial of treatment sequences in BRAFV600-mutant (m) metastatic melanoma (MM)—Final clinical results.
Interested in learning more about these abstracts and other trials presented at ASCO® 2025? Be sure to register for one of our licensed Best of ASCO® events in a city near you.
This program has been made possible through unrestricted support from Boehringer Ingelheim, Eli Lilly and Ipsen
